SEC Form 4 · accession 0001209191-18-015945
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Kevin C Tang
Director · 10% Owner
TANG CAPITAL PARTNERS LP
10% Owner
TANG CAPITAL MANAGEMENT LLC
10% Owner
Period of report
Mar 2, 2018
Accepted (ET)
Mar 2, 2018 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2018 | P | 10,000 | $29.5381 | A | 3,600,419 | I | By LP |
| Common StockF1 | Feb 28, 2018 | P | 10,000 | $30.1171 | A | 3,610,419 | I | By LP |
| Common StockF1 | Feb 28, 2018 | P | 10,000 | $30.154 | A | 3,620,419 | I | By LP |
| Common StockF1 | Mar 2, 2018 | P | 10,000 | $30.4435 | A | 3,630,419 | I | By LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP.